These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7373531

  • 1. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits.
    Schoenwald RD, Stewart P.
    J Pharm Sci; 1980 Apr; 69(4):391-4. PubMed ID: 7373531
    [Abstract] [Full Text] [Related]

  • 2. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
    Zhang L, Zhang J, Wang L, Xia H.
    Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
    [Abstract] [Full Text] [Related]

  • 3. Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: Bioavailability comparison.
    Naageshwaran V, Ranta VP, Toropainen E, Tuomainen M, Gum G, Xie E, Bhoopathy S, Urtti A, Del Amo EM.
    Int J Pharm; 2022 Mar 05; 615():121515. PubMed ID: 35091006
    [Abstract] [Full Text] [Related]

  • 4. Ocular absorption of dexamethasone phosphate disodium by the rabbit.
    Rosenblum C, Dengler RE, Geoffroy RF.
    Arch Ophthalmol; 1967 Feb 05; 77(2):234-7. PubMed ID: 6019020
    [No Abstract] [Full Text] [Related]

  • 5. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y.
    Int J Pharm; 2010 Aug 30; 396(1-2):179-87. PubMed ID: 20558263
    [Abstract] [Full Text] [Related]

  • 6. Effect of derivatization of the bioavailability of ophthalmic steroids. Development of an in vitro method of evaluation.
    Flint GR, Morton DJ.
    Arch Ophthalmol; 1984 Dec 30; 102(12):1808-9. PubMed ID: 6548906
    [Abstract] [Full Text] [Related]

  • 7. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
    Zhang J, Wang L, Gao C, Zhang L, Xia H.
    J Ocul Pharmacol Ther; 2008 Oct 30; 24(5):501-6. PubMed ID: 18803444
    [Abstract] [Full Text] [Related]

  • 8. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
    Sun KX, Wang AP, Huang LJ, Liang RC, Liu K.
    Yao Xue Xue Bao; 2006 Nov 30; 41(11):1094-8. PubMed ID: 17262954
    [Abstract] [Full Text] [Related]

  • 9. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
    Le Merdy M, Fan J, Bolger MB, Lukacova V, Spires J, Tsakalozou E, Patel V, Xu L, Stewart S, Chockalingam A, Narayanasamy S, Rouse R, Matta M, Babiskin A, Kozak D, Choi S, Zhang L, Lionberger R, Zhao L.
    AAPS J; 2019 May 20; 21(4):65. PubMed ID: 31111305
    [Abstract] [Full Text] [Related]

  • 10. Biological equivalence of ophthalmic prednisolone acetate suspensions.
    Kupferman A, Leibowitz HM.
    Am J Ophthalmol; 1976 Jul 20; 82(1):109-13. PubMed ID: 937444
    [Abstract] [Full Text] [Related]

  • 11. Comparison of ophthalmic bioavailability of two dexamethasone derivatives in proprietary preparations.
    Morton DJ, Flint GR.
    Cent Afr J Med; 1985 Feb 20; 31(2):32-4. PubMed ID: 3839168
    [No Abstract] [Full Text] [Related]

  • 12. Effect of particle dissolution rate on ocular drug bioavailability.
    Hui HW, Robinson JR.
    J Pharm Sci; 1986 Mar 20; 75(3):280-7. PubMed ID: 3701612
    [Abstract] [Full Text] [Related]

  • 13. Topically applied steroids in corneal disease. V. Dexamethasone alcohol.
    Kupferman A, Leibowitz HM.
    Arch Ophthalmol; 1974 Oct 20; 92(4):329-30. PubMed ID: 4416662
    [No Abstract] [Full Text] [Related]

  • 14. Intraocular fate of dexamethasone disodium phosphate topically applied to the eyes of rabbits.
    Ichigashira N, Yamaga N.
    Steroids; 1978 Dec 20; 32(5):615-28. PubMed ID: 734696
    [Abstract] [Full Text] [Related]

  • 15. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
    Zhang JJ, Gao CF, Wang LY.
    Zhonghua Yan Ke Za Zhi; 2006 Jul 20; 42(7):637-41. PubMed ID: 17081425
    [Abstract] [Full Text] [Related]

  • 16. Topically applied steroids in corneal disease. 3. The role of drug derivative in stromal absorption of dexamethasone.
    Kupferman A, Pratt MV, Suckewer K, Leibowitz HM.
    Arch Ophthalmol; 1974 May 20; 91(5):373-6. PubMed ID: 4821791
    [No Abstract] [Full Text] [Related]

  • 17. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M, Inoue A, Sasaki K, Takahashi N.
    Jpn J Ophthalmol; 2004 May 20; 48(2):93-6. PubMed ID: 15060787
    [Abstract] [Full Text] [Related]

  • 18. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
    Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM.
    Int J Pharm; 2007 Aug 01; 340(1-2):126-33. PubMed ID: 17600645
    [Abstract] [Full Text] [Related]

  • 19. [Ocular penetration of dexamethasone sodium phosphate via soft contact lenses].
    Goto S, Fujiwara H, Egi K, Katayama T, Suzuki T.
    Nippon Ganka Gakkai Zasshi; 1989 Feb 01; 93(2):254-7. PubMed ID: 2788978
    [Abstract] [Full Text] [Related]

  • 20. A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension.
    Johansen S, Rask-Pedersen E, Prause JU.
    Acta Ophthalmol Scand; 1996 Jun 01; 74(3):253-8. PubMed ID: 8828722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.